Title : Darunavir/ritonavir and efavirenz exert differential effects on MRP1 transporter expression and function in healthy volunteers.

Pub. Date : 2010

PMID : 20386083






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Darunavir/ritonavir and efavirenz exert differential effects on MRP1 transporter expression and function in healthy volunteers. Darunavir CD9 molecule Homo sapiens
2 We studied MRP1 expression and function in healthy volunteers treated with darunavir/ritonavir and efavirenz. Darunavir CD9 molecule Homo sapiens
3 MRP1 efflux function was increased after efavirenz administration (GMR 3.13, 95% CI 2.73-3.59; P<0.001) and darunavir/ritonavir plus efavirenz coadministration (GMR 4.35, 95% CI 3.35-5.68; P<0.001), but not after darunavir/ritonavir administration (GMR 1.06, 95% CI 0.80-1.42; P=0.42). Darunavir CD9 molecule Homo sapiens
4 MRP1 efflux function was increased after efavirenz administration (GMR 3.13, 95% CI 2.73-3.59; P<0.001) and darunavir/ritonavir plus efavirenz coadministration (GMR 4.35, 95% CI 3.35-5.68; P<0.001), but not after darunavir/ritonavir administration (GMR 1.06, 95% CI 0.80-1.42; P=0.42). Darunavir CD9 molecule Homo sapiens
5 CONCLUSIONS: Darunavir/ritonavir and efavirenz treatment exerted differential effects on MRP1 expression and function. Darunavir CD9 molecule Homo sapiens